Our fast-acting formula is rich in micronutrients, prebiotics, and antimicrobial properties, and is clinically shown to quickly reduce digestive distress in GLP-1 users
Scientific References TripleHormone-Receptor Agonist Retatrutide for Obesity (Jastreboff et al., 2023)
Their results demonstrate that GLP-1, through an unknown mechanism, can preserve axonal and neurofilament structure despite the induction of progressive neurotoxicity, thus illustrating neuroprotective properties that can be leveraged against disorders in the central nervous system [60]
It is not intended for human consumption, medical use, diagnostic use, therapeutic use, weight-loss use, appetite-control use, glucose-management use, diabetes treatment use, obesity treatment use, supplement use, injection use, or the treatment, prevention, or diagnosis of any disease